Express Scripts reports slower rise in drug spending

In its annual drug trend report, Express Scripts Holding Co. (NASDAQ:ESRX) said prescription drug spending by its clients rose by 3.8% in 2016, down from 5.2% in 2015.

Since the start of 2015, the PBM has launched cost-saving initiatives such as its Hepatitis Cure and Diabetes Care Value Programs, as well as an indication-based pricing model for cancer. A second indication-based model for inflammatory diseases is being implemented as well (see BioCentury Extra, April 28, 2016)...